|
The impact of metastatic breast cancer (mBC) treatment on patient reported productivity loss among patients with HER2+ mBC in the U.S. |
| |
|
Employment - Daiichi Sankyo |
Stock and Other Ownership Interests - Daiichi Sankyo |
| |
Cherrishe Brown-Bickerstaff |
Employment - Cardinal Health |
Research Funding - Ascentage Pharma (Inst); Blue Note Therapeutics; Bristol Myers Squibb (Inst); Celgene/Bristol-Myers Squibb (Inst); Daiichi Sankyo/Lilly (Inst); Eisai (Inst); EmitBio (Inst); Greenwich Biosciences (Inst); Incyte (Inst); Pfizer (Inst) |
| |
|
Employment - Cardinal Health |
Stock and Other Ownership Interests - Cardinal Health |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Travel, Accommodations, Expenses - GE Healthcare |
| |
|
Employment - Daiichi Sankyo, Inc. |
| |
|
Employment - Cardinal Health |
Leadership - Cardinal Health |
Stock and Other Ownership Interests - Cardinal Health |